Relation of quality of anticoagulation control with different management systems among patients with atrial fibrillation: Data from <scp>FANTASIIA</scp> Registry

Rabadán, Inmaculada Roldán; Esteve-Pastor, María Asunción; Anguita‐Sánchez, Manuel; Muñiz, Javier; Siles, José Camacho; Quesada, María Angustias; Ortiz, Martín Ruiz; Marı́n, Francisco; Sellés, Manuel Martínez; Bertoméu, Vicente; Lip, Gregory Y.H.; Fillat, Ángel Cequier; Badimón, Lina; Investigators, Fantasiia Study

doi:10.1111/eci.12910

Cited by 5 publications

(3 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…One study in China (36) showed the percentage of people with TTR≥70 was only 10.7% while TTR ≤ 70% was 89.3% which indicated poor anticoagulation control of warfarin therapy in both countries. Interestingly, Nguyen et al (28) also reported lower TTR among their 512 Indigenous vs. nonindigenous Australian patients with AF [40 (29) vs. 50 (31); p = 0.006]. Based on the previous study by Golwala et al (37) black individuals had lower median TTRs (59%) than Hispanic (62%) and white (68%) participants; consistent with findings from the sub study of IMPACT trial (38).…”

Section: Time In Therapeutic Range Among Warfarin Users Within Different Ethnic Groupsmentioning

confidence: 55%

“…Among the 18 studies ( 9 , 26 – 42 ) from the findings, eight studies ( 27 , 28 , 32 , 33 , 37 – 39 , 42 ) stated TTR among each specific ethnic groups in their population and the other 10 studies ( 9 , 29 – 31 , 34 – 37 , 40 , 41 ) only mentioned the TTR in their overall population (whites, Asians). So far, in Malaysia, there is no study being conducted that focused on TTR among different ethnic groups.…”

Section: Time In Therapeutic Range Among Warfarin Users Within Different Ethnic Groupsmentioning

confidence: 99%

See 1 more Smart Citation

Anticoagulation Control in Different Ethnic Groups Receiving Vitamin K Antagonist for Stroke Prevention in Atrial Fibrillation

Zawawi

Zaki

Ming

et al. 2021

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

Vitamin K antagonist such as warfarin reduces the risk of stroke in atrial fibrillation (AF) patients. Since warfarin has a narrow therapeutic index, its administration needs to be regularly monitored to avoid any adverse clinical outcomes such as stroke and bleeding. The quality of anticoagulation control with warfarin therapy can be measured by using time in therapeutic range (TTR). This review focuses on the prevalence of AF, quality of anticoagulation control (TTR) and adverse clinical outcome in AF patients within different ethnic groups receiving warfarin therapy for stroke prevention. A literature search was conducted in Embase and PubMed using keywords of “prevalence,” “atrial fibrillation,” “stroke prevention,” “oral anticoagulants,” “warfarin,” “ethnicities,” “race” “time in therapeutic range,” “adverse clinical outcome,” “stroke, bleeding.” Articles published by 1st February 2020 were included. Forty-one studies were included in the final review consisting of AF prevalence (n = 14 studies), time in therapeutic range (n = 18 studies), adverse clinical outcome (n = 9 studies) within different ethnic groups. Findings indicate that higher prevalence of AF but better anticoagulation control among the Whites as compared to other ethnicities. Of note, non-whites had higher risk of strokes and bleeding outcomes while on warfarin therapy. Addressing disparities in prevention and healthcare resource allocation could potentially improve AF-related outcomes in minorities.

show abstract

Section: Time In Therapeutic Range Among Warfarin Users Within Different Ethnic Groupsmentioning

confidence: 55%

Section: Time In Therapeutic Range Among Warfarin Users Within Different Ethnic Groupsmentioning

confidence: 99%

Anticoagulation Control in Different Ethnic Groups Receiving Vitamin K Antagonist for Stroke Prevention in Atrial Fibrillation

Zawawi

Zaki

Ming

et al. 2021

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

show abstract

“…, 27. - 28 . Esto tiene una gran importancia, ya que el mal control de la anticoagulación se asocia con un mayor riesgo de episodios adversos.…”

Section: ¿Qué Dicen Los Ensayos Clínicos?unclassified

Prevención del ictus en pacientes con fibrilación auricular. Mejorar la protección enla era de la COVID-19

Vallejo

Fillat

García

et al. 2021

Revista Española de Cardiología Suplementos

View full text Add to dashboard Cite

Relationship between multimorbidity and outcomes in atrial fibrillation

Proietti

Esteve‐Pastor

Rivera‐Caravaca

et al. 2021

Experimental Gerontology

Self Cite

View full text Add to dashboard Cite

Relation of quality of anticoagulation control with different management systems among patients with atrial fibrillation: Data from FANTASIIA Registry

Abstract: About 60% of AF patients anticoagulated with VKAs had poor anticoagulation control (ie TTR<70%), and their management was only slightly better than when it is managed by general practitioners.

Cited by 5 publications

References 36 publications

Anticoagulation Control in Different Ethnic Groups Receiving Vitamin K Antagonist for Stroke Prevention in Atrial Fibrillation

Anticoagulation Control in Different Ethnic Groups Receiving Vitamin K Antagonist for Stroke Prevention in Atrial Fibrillation

Prevención del ictus en pacientes con fibrilación auricular. Mejorar la protección enla era de la COVID-19

Relationship between multimorbidity and outcomes in atrial fibrillation

Contact Info

Product

Resources

About